SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 7.840+0.4%Aug 12 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred11/15/2013 10:54:46 AM
  Read Replies (1) of 6364
 
Merck KGaA says eyes acquisitions at all four units
DARMSTADT, Germany Thu Nov 14, 2013 5:30am EST






(Reuters) - Germany's Merck KGaA ( MRCG.DE) said it would look into possible acquisitions to strengthen all of its four business divisions - prescription drugs, non-prescription drugs, laboratory equipment and specialty chemicals.

"We have four sustainable business divisions that are set to grow organically, but for all four areas we have ideas for steps that go beyond that," Chief Executive Karl-Ludwig Kley told journalists at a press conference on Thursday.

"But the main point is the continuation of our financial discipline," he added.

reuters.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext